{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:31:55Z","timestamp":1786365115640,"version":"build-2736575974"},"reference-count":66,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Geriatrics"],"abstract":"<jats:p>Polypharmacy in older adults is common, rising and inconsistently defined, and it is widely treated as a problem of how many medicines a person takes. This non-systematic narrative review argues that its harm depends more on the appropriateness of the regimen and the pharmacological burden the regimen imposes, with the number of drugs a partly confounded marker rather than the principal cause. Drawing on evidence published mainly since 2020, it traces the shift from counting medicines to weighting them; the prescribing cascade as a patterned and detectable source of inappropriate use; the explicit criteria (Beers, STOPP\/START, EURO-FORTA) and implicit measures (the Medication Appropriateness and Drug Burden indices) that give appropriateness operational form; and the evidence that deprescribing is feasible and generally safe, although its benefit is conditional and depends on how it is done. Because these criteria can be applied to medication lists held in routine data, potentially inappropriate prescribing can increasingly be identified beyond the single encounter and at population scale, even as automated tools remain unreliable at judging whether a flagged criterion applies to the individual patient. The review concludes that medication review should prioritise appropriateness and the individual benefit\u2013risk balance rather than the medication count, and that detection can increasingly be scaled even though the clinical decision and the patient\u2019s agreement cannot.<\/jats:p>","DOI":"10.3390\/geriatrics11040100","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:38:09Z","timestamp":1786361889000},"page":"100","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Appropriateness over Numbers: Pharmacological Burden and Scalable Medication Review in Older Adults"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2545-9018","authenticated-orcid":false,"given":"Micha\u0142","family":"Pstr\u0105gowski","sequence":"first","affiliation":[{"name":"Institute of Clinical Sciences, Maria Sklodowska-Curie Medical Academy in Warsaw, Plac \u017belaznej Bramy 10, 00-136 Warsaw, Poland"},{"name":"Medical Department, leki.pl Sp. z o.o., Rtm. Witolda Pileckiego 67\/109, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4810-721X","authenticated-orcid":false,"given":"Dawid","family":"Hachlica","sequence":"additional","affiliation":[{"name":"Medical Department, leki.pl Sp. z o.o., Rtm. Witolda Pileckiego 67\/109, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Izbicki","sequence":"additional","affiliation":[{"name":"Medical Department, leki.pl Sp. z o.o., Rtm. Witolda Pileckiego 67\/109, 02-781 Warsaw, Poland"},{"name":"Department of Drug Technology and Pharmaceutical Biotechnology, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","article-title":"Polypharmacy in Older Adults: A Narrative Review of Definitions, Epidemiology and Consequences","volume":"12","author":"Pazan","year":"2021","journal-title":"Eur. Geriatr. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1016\/S2666-7568(24)00007-2","article-title":"Prevalence of Multimorbidity and Polypharmacy among Adults and Older Adults: A Systematic Review","volume":"5","author":"Nicholson","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Masnoon, N., Shakib, S., Kalisch-Ellett, L., and Caughey, G.E. (2017). What Is Polypharmacy? A Systematic Review of Definitions. BMC Geriatr., 17.","DOI":"10.1186\/s12877-017-0621-2"},{"key":"ref_4","unstructured":"World Health Organization (2019). Medication Safety in Polypharmacy, World Health Organization. WHO\/UHC\/SDS\/2019.11."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","article-title":"Polypharmacy Cutoff and Outcomes: Five or More Medicines Were Used to Identify Community-Dwelling Older Men at Risk of Different Adverse Outcomes","volume":"65","author":"Gnjidic","year":"2012","journal-title":"J. Clin. Epidemiol."},{"key":"ref_6","unstructured":"Duerden, M., Avery, T., and Payne, R. (2013). Polypharmacy and Medicines Optimisation: Making It Safe and Sound, The King\u2019s Fund."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7812\/TPP\/18.212","article-title":"Refining the Definition of Polypharmacy and Its Link to Disability in Older Adults: Conceptualizing Necessary Polypharmacy, Unnecessary Polypharmacy, and Polypharmacy of Unclear Benefit","volume":"24","author":"Lee","year":"2020","journal-title":"Perm. J."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Delara, M., Murray, L., Jafari, B., Bahji, A., Goodarzi, Z., Kirkham, J., Chowdhury, M., and Seitz, D.P. (2022). Prevalence and Factors Associated with Polypharmacy: A Systematic Review and Meta-Analysis. BMC Geriatr., 22, Correction in BMC Geriatr.\u00a02022, 22, 742.","DOI":"10.1186\/s12877-022-03388-7"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41256-023-00311-4","article-title":"Prevalence and Trends of Polypharmacy in U.S. Adults, 1999\u20132018","volume":"8","author":"Wang","year":"2023","journal-title":"Glob. Health Res. Policy"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.archger.2018.06.018","article-title":"Polypharmacy Prevalence among Older Adults Based on the Survey of Health, Ageing and Retirement in Europe","volume":"78","author":"Giardini","year":"2018","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bonanno, E.G., Figueiredo, T., Mimoso, I.F., Morgado, M.I., Carrilho, J., Mid\u00e3o, L., and Costa, E. (2025). Polypharmacy Prevalence among Older Adults Based on the Survey of Health, Ageing and Retirement in Europe: An Update. J. Clin. Med., 14.","DOI":"10.3390\/jcm14041330"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e008656","DOI":"10.1136\/bmjopen-2015-008656","article-title":"Trends and Interaction of Polypharmacy and Potentially Inappropriate Prescribing in Primary Care over 15 Years in Ireland: A Repeated Cross-Sectional Study","volume":"5","author":"Moriarty","year":"2015","journal-title":"BMJ Open"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Guthrie, B., Makubate, B., Hernandez-Santiago, V., and Dreischulte, T. (2015). The Rising Tide of Polypharmacy and Drug-Drug Interactions: Population Database Analysis 1995\u20132010. BMC Med., 13.","DOI":"10.1186\/s12916-015-0322-7"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/CLEP.S153458","article-title":"The Epidemiology of Polypharmacy in Older Adults: Register-Based Prospective Cohort Study","volume":"10","author":"Morin","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/gerona\/glr233","article-title":"Polypharmacy in Nursing Home in Europe: Results from the SHELTER Study","volume":"67","author":"Onder","year":"2012","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lai, X., Zhu, H., Huo, X., and Li, Z. (2018). Polypharmacy in the Oldest Old (\u226580 Years of Age) Patients in China: A Cross-Sectional Study. BMC Geriatr., 18.","DOI":"10.1186\/s12877-018-0754-y"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A Drug Burden Index to Define the Functional Burden of Medications in Older People","volume":"167","author":"Hilmer","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing Inappropriate Polypharmacy: The Process of Deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014A Scale for the Quality Assessment of Narrative Review Articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Sheikh-Taha, M., and Asmar, M. (2021). Polypharmacy and Severe Potential Drug-Drug Interactions among Older Adults with Cardiovascular Disease in the United States. BMC Geriatr., 21.","DOI":"10.1186\/s12877-021-02183-0"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/jgs.18305","article-title":"Dietary Supplement and Complementary and Alternative Medicine Use Among Older Adults in Australia and the United States","volume":"71","author":"Fravel","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Moran, R., Baird, S., DiGuiseppi, C.G., Eby, D.W., Hacker, S., Isom, C., Jones, V., Lee, K.C., Li, G., and Molnar, L.J. (2024). Dietary Supplement Use Is Common in Older Adult Drivers: An Analysis from the AAA LongROAD Study. BMC Complement. Med. Ther., 24.","DOI":"10.1186\/s12906-024-04623-x"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(17)31188-1","article-title":"The Prescribing Cascade Revisited","volume":"389","author":"Rochon","year":"2017","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e1918425","DOI":"10.1001\/jamanetworkopen.2019.18425","article-title":"Magnitude of and Characteristics Associated with the Treatment of Calcium Channel Blocker\u2013Induced Lower-Extremity Edema with Loop Diuretics","volume":"2","author":"Vouri","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1111\/jgs.19191","article-title":"Identifying and Quantifying Potentially Problematic Prescribing Cascades in Clinical Practice: A Mixed-Methods Study","volume":"72","author":"Mohammad","year":"2024","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1370\/afm.240383","article-title":"Prescribing Cascades among Older Community-Dwelling Adults: Application of Prescription Sequence Symmetry Analysis to a National Database in Ireland","volume":"23","author":"Doherty","year":"2025","journal-title":"Ann. Fam. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e01008","DOI":"10.1002\/prp2.1008","article-title":"Prescribing Cascades in Community-Dwelling Adults: A Systematic Review","volume":"10","author":"Doherty","year":"2022","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40266-023-01072-y","article-title":"Prescribing Cascades with Recommendations to Prevent or Reverse Them: A Systematic Review","volume":"40","author":"Adrien","year":"2023","journal-title":"Drugs Aging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/pds.5362","article-title":"Evaluation of the Key Prescription Sequence Symmetry Analysis Assumption Using the Calcium Channel Blocker: Loop Diuretic Prescribing Cascade","volume":"31","author":"Vouri","year":"2022","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"104630","DOI":"10.1016\/j.archger.2022.104630","article-title":"Association between Polypharmacy and Mortality in the Older Adults: A Systematic Review and Meta-Analysis","volume":"100","author":"Li","year":"2022","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Costanzo, S., Di Castelnuovo, A., Panzera, T., De Curtis, A., Falciglia, S., Persichillo, M., Cerletti, C., Donati, M.B., de Gaetano, G., and Iacoviello, L. (2024). Polypharmacy in Older Adults: The Hazard of Hospitalization and Mortality Is Mediated by Potentially Inappropriate Prescriptions, Findings from the Moli-sani Study. Int. J. Public Health, 69.","DOI":"10.3389\/ijph.2024.1607682"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e055551","DOI":"10.1136\/bmjopen-2021-055551","article-title":"Adverse Drug Reactions, Multimorbidity and Polypharmacy: A Prospective Analysis of 1 Month of Medical Admissions","volume":"12","author":"Osanlou","year":"2022","journal-title":"BMJ Open"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e8525","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent Use of Diuretics, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers with Non-Steroidal Anti-Inflammatory Drugs and Risk of Acute Kidney Injury: Nested Case-Control Study","volume":"346","author":"Lapi","year":"2013","journal-title":"BMJ"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/bcp.14094","article-title":"Prescribing Medicines to Older People\u2014How to Consider the Impact of Ageing on Human Organ and Body Functions","volume":"86","author":"Wilting","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1060028019886846","article-title":"Are Clinical Outcomes Associated with Medication Regimen Complexity? A Systematic Review and Meta-Analysis","volume":"54","author":"Rocha","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1007\/s11136-022-03136-9","article-title":"Polypharmacy and Trajectories of Health-Related Quality of Life in Older Adults: An Australian Cohort Study","volume":"31","author":"Aljeaidi","year":"2022","journal-title":"Qual. Life Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exger.2019.02.019","article-title":"The Relationship between Polypharmacy and Trajectories of Cognitive Decline in People with Dementia: A Large Representative Cohort Study","volume":"120","author":"Soysal","year":"2019","journal-title":"Exp. Gerontol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/CLEP.S201614","article-title":"Polypharmacy and Injurious Falls in Older Adults: A Nationwide Nested Case-Control Study","volume":"11","author":"Morin","year":"2019","journal-title":"Clin. Epidemiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"108206","DOI":"10.1016\/j.amepre.2025.108206","article-title":"Polypharmacy as a Simple Measure for Assessing the Risk of Fall-Related Hospitalization in Older Adults","volume":"70","author":"Gagnon","year":"2026","journal-title":"Am. J. Prev. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zaninotto, P., Huang, Y.T., Di Gessa, G., Abell, J., Lassale, C., and Steptoe, A. (2020). Polypharmacy Is a Risk Factor for Hospital Admission Due to a Fall: Evidence from the English Longitudinal Study of Ageing. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-09920-x"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7326\/0003-4819-146-2-200701160-00004","article-title":"Effect of New York State Regulatory Action on Benzodiazepine Prescribing and Hip Fracture Rates","volume":"146","author":"Wagner","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0895-4356(92)90144-C","article-title":"A Method for Assessing Drug Therapy Appropriateness","volume":"45","author":"Hanlon","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0895-4356(94)90192-9","article-title":"A Summated Score for the Medication Appropriateness Index: Development and Assessment of Clinimetric Properties Including Content Validity","volume":"47","author":"Samsa","year":"1994","journal-title":"J. Clin. Epidemiol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"(2023). By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2023 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. J. Am. Geriatr. Soc., 71, 2052\u20132081.","DOI":"10.1111\/jgs.18372"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START Criteria for Potentially Inappropriate Prescribing in Older People: Version 3","volume":"14","author":"Cherubini","year":"2023","journal-title":"Eur. Geriatr. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s40266-023-01024-6","article-title":"The EURO-FORTA (Fit fOR The Aged) List Version 2: Consensus Validation of a Clinical Tool for Improved Pharmacotherapy in Older Adults","volume":"40","author":"Pazan","year":"2023","journal-title":"Drugs Aging"},{"key":"ref_47","first-page":"3","article-title":"Potentially Inadequate Medications in the Elderly: PRISCUS 2.0","volume":"120","author":"Mann","year":"2023","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ageing\/afaa159","article-title":"Deprescribing in Older People Approaching End-of-Life: Development and Validation of STOPPFrail Version 2","volume":"50","author":"Curtin","year":"2021","journal-title":"Age Ageing"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e2326910","DOI":"10.1001\/jamanetworkopen.2023.26910","article-title":"Prevalence of Use of Potentially Inappropriate Medications Among Older Adults Worldwide: A Systematic Review and Meta-Analysis","volume":"6","author":"Tian","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"afab269","DOI":"10.1093\/ageing\/afab269","article-title":"Inappropriate Prescribing: Hazards and Solutions","volume":"51","author":"Petrovic","year":"2022","journal-title":"Age Ageing"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40266-018-0549-z","article-title":"Anticholinergic Drug Burden Tools\/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews","volume":"35","author":"Welsh","year":"2018","journal-title":"Drugs Aging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00228-020-02994-x","article-title":"Quality of Anticholinergic Burden Scales and Their Impact on Clinical Outcomes: A Systematic Review","volume":"77","author":"Lisibach","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1111\/bcp.16200","article-title":"The Effect of Deprescribing Interventions on Mortality and Health Outcomes in Older People: An Updated Systematic Review and Meta-Analysis","volume":"90","author":"Quek","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"n1585","DOI":"10.1136\/bmj.n1585","article-title":"Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): Cluster Randomised Controlled Trial","volume":"374","author":"Blum","year":"2021","journal-title":"BMJ"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/bcpt.13921","article-title":"How Does Deprescribing (Not) Reduce Mortality? A Review of a Meta-Analysis in Community-Dwelling Older Adults Casts Uncertainty Over Claimed Benefits","volume":"134","author":"Sirois","year":"2024","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of Inappropriate Benzodiazepine Prescriptions Among Older Adults Through Direct Patient Education: The EMPOWER Cluster Randomized Trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jama.2020.4871","article-title":"Effect of Antihypertensive Medication Reduction vs Usual Care on Short-Term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial","volume":"323","author":"Sheppard","year":"2020","journal-title":"JAMA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e035978","DOI":"10.1136\/bmjopen-2019-035978","article-title":"Deprescribing Fall-Risk-Increasing Drugs (FRIDs) for the Prevention of Falls and Fall-Related Complications: A Systematic Review and Meta-Analysis","volume":"11","author":"Lee","year":"2021","journal-title":"BMJ Open"},{"key":"ref_59","first-page":"112019","article-title":"Identifying Potentially Inappropriate Prescribing in Entire Populations: Coding the STOPP\/START and Beers Criteria for Use with Large, Routinely Collected Population Health Datasets","volume":"187","author":"Bjerre","year":"2025","journal-title":"J. Clin. Epidemiol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Hu, Q., Tian, F., Jin, Z., Lin, G., Teng, F., and Xu, T. (2023). Developing a Warning Model of Potentially Inappropriate Medications in Older Chinese Outpatients in Tertiary Hospitals: A Machine-Learning Study. J. Clin. Med., 12.","DOI":"10.21203\/rs.3.rs-2400761\/v1"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jval.2024.06.005","article-title":"Traditional Methods Hold Their Ground Against Machine Learning in Predicting Potentially Inappropriate Medication Use in Older Adults","volume":"27","author":"Chiu","year":"2024","journal-title":"Value Health"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e69504","DOI":"10.2196\/69504","article-title":"Identifying Deprescribing Opportunities with Large Language Models in Older Adults: Retrospective Cohort Study","volume":"8","author":"Socrates","year":"2025","journal-title":"JMIR Aging"},{"key":"ref_63","first-page":"e90867","article-title":"Artificial Intelligence in the Management of Polypharmacy Among Older Adults: A Scoping Review","volume":"17","author":"Bringhurst","year":"2025","journal-title":"Cureus"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1007\/s11606-021-06965-5","article-title":"How Willing Are Patients or Their Caregivers to Deprescribe: A Systematic Review and Meta-Analysis","volume":"36","author":"Chock","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"bjgpopen20X101096","DOI":"10.3399\/bjgpopen20X101096","article-title":"Barriers and Facilitators to Deprescribing in Primary Care: A Systematic Review","volume":"4","author":"Doherty","year":"2020","journal-title":"BJGP Open"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ageing\/afaa002","article-title":"Successful Care Transitions for Older People: A Systematic Review and Meta-Analysis of the Effects of Interventions That Support Medication Continuity","volume":"49","author":"Tomlinson","year":"2020","journal-title":"Age Ageing"}],"container-title":["Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3417\/11\/4\/100\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:01:04Z","timestamp":1786363264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3417\/11\/4\/100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["geriatrics11040100"],"URL":"https:\/\/doi.org\/10.3390\/geriatrics11040100","relation":{},"ISSN":["2308-3417"],"issn-type":[{"value":"2308-3417","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}